CD8A and neoplasm: Notably, type I IFN signaling in dendritic cell (DCs) has been shown to be critical for initiation of anti-tumor CD8+ T cell responses by promoting presentation of tumor-derived antigens and expression of pro-inflammatory cytokines and chemokines [2, 3].